Last reviewed · How we verify
XingZaoRuanJian
At a glance
| Generic name | XingZaoRuanJian |
|---|---|
| Also known as | RuanHuaTang |
| Sponsor | Shanghai University of Traditional Chinese Medicine |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Curative Study of Chinese Traditional Medicine to Treat Lung Cancer (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- XingZaoRuanJian CI brief — competitive landscape report
- XingZaoRuanJian updates RSS · CI watch RSS
- Shanghai University of Traditional Chinese Medicine portfolio CI